7 results found.

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Breast Clinical Trial using veliparib; carboplatin; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase II Trial of Single Agent ABT-888 With Post-Progression Therapy of ABT-888 in Combination With Carboplatin in Patients With Stage IV BRCA-associated Breast Cancer.
veliparib; carboplatin; laboratory biomarker analysis

Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Clinical Trial using questionnaire administration; quality-of-life assessment; management of therapy complications; exercise intervention

University of Southern California - Recruiting 18 years or older.
- Combined Exercise Program for Early Breast Cancer Survivors.
questionnaire administration; quality-of-life assessment; management of therapy complications; exercise intervention

Estrogen Receptor-positive Breast Cancer, Stage I Breast Cancer, Clinical Trial using tamoxifen citrate; polymerase chain reaction; pharmacological study; gene expression analysis; immunohistochemistry staining method; pharmacogenomic studies; matrix-assisted laser desorption/ionization time of flight mass spectrometry; polymorphism analysis; therapeutic conventional surgery; nucleic acid sequencing; protein analysis

Roswell Park Cancer Institute - Recruiting 18 years or older.
- Pilot Study to Analyze a Novel Mechanism Underlying Response to Tamoxifen Therapy in Breast Cancer Patients.
tamoxifen citrate; polymerase chain reaction; pharmacological study; gene expression analysis; immunohistochemistry staining method; pharmacogenomic studies; matrix-assisted laser desorption/ionization time of flight mass spectrometry; polymorphism analysis; therapeutic conventional surgery; nucleic acid sequencing; protein analysis

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Ca Clinical Trial using Paclitaxel; Carboplatin; Doxorubicin; Cyclophosphamide; Veliparib

Thomas Jefferson University - Recruiting 18 years or older.
- An Adaptive, Randomized Phase II Trial to Determine Pathologic Complete Response With the Addition of Carboplatin With and Without Veliparib to Standard Chemotherapy in the Neoadjuvant Treatment of Triple-Negative Breast Cancer.
Paclitaxel; Carboplatin; Doxorubicin; Cyclophosphamide; Veliparib

Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Brea Clinical Trial using paclitaxel; trastuzumab; doxorubicin hydrochloride; cyclophosphamide; laboratory biomarker analysis; cytology specimen collection procedure

Albert Einstein College of Medicine of Yeshiva University - Recruiting 18 years or older.
- Prospective Tissue Collection in Breast Cancer Patients Receiving Preoperative Systemic Therapy.
paclitaxel; trastuzumab; doxorubicin hydrochloride; cyclophosphamide; laboratory biomarker analysis; cytology specimen collection procedure

Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-p Clinical Trial using therapeutic estradiol; exemestane; laboratory biomarker analysis; enzyme-linked immunosorbent assay

University of Arizona - Recruiting N/A or older.
- A Pilot Study Of Estradiol Followed By Exemestane For Post-Menopausal Hormone Receptor Positive Metastatic Breast Cancer After Prior Failed Endocrine Therapy: Reversing Endocrine Resistance.
therapeutic estradiol; exemestane; laboratory biomarker analysis; enzyme-linked immunosorbent assay

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Ca Clinical Trial using mifepristone; placebo; nab-paclitaxel

University of Chicago - Recruiting 18 years or older.
- A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer.
mifepristone; placebo; nab-paclitaxel